Log in

Ibrutinib-associated symptomatic intracerebral haemorrhage following IV thrombolysis for acute ischaemic stroke

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Spain)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Availability of data and material

No additional data or material are available.

Code availability

Not applicable.

References

  1. Wang M, Blum K, Martin P, Goy A, Auer R, Kahl B et al (2015) Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood 126:739–745

    Article  CAS  Google Scholar 

  2. Shatzel J, Olson S, Tao D, McCarty O, Danilov A, DeLoughery T (2017) Ibrutinib-associated bleeding; pathogenesis, management, and risk reduction strategies. J Thromb Haemost 15:835–847

    Article  CAS  Google Scholar 

  3. Quintavalla R, Lombardi M, Prandoni P, Manotti C, Tadonio I, Re F et al (2018) Increased dabigatran plasma concentration during Ibrutinib treatment: a case of cerebral hemorrhage and successful dabigatran reversal by idarucizumab. Aging Clin Exp Res 30:93–95

    Article  CAS  Google Scholar 

  4. Allouchery M, Tomowiak C, Guidez S, Delwail V, Delaunay P, Lafay-Chebassier C et al (2021) Patterns of use and safety of ibrutinib in real-life practice. Br J Clin Pharmacol 87:895–904

    Article  CAS  Google Scholar 

  5. Yaghi S, Willey J, Cucchiara B, Goldstein J, Gonzales N, Khatri P et al (2017) Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 48:e343–e361

    PubMed  Google Scholar 

Download references

Funding

No funding was received to assist with the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katrijn Madou.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Madou, K., Carrette, S., Acou, M. et al. Ibrutinib-associated symptomatic intracerebral haemorrhage following IV thrombolysis for acute ischaemic stroke. Acta Neurol Belg 122, 1111–1113 (2022). https://doi.org/10.1007/s13760-022-01935-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-022-01935-y

Keywords

Navigation